Non-alcoholic steatohepatitis (NASH) is an advanced form of non-alcoholic fatty liver disease that commonly goes undetected and leads to serious consequences such as liver transplant. Explore your NASH clinical research participation options.
In the early stages of fatty liver disease, there are typically minimal or no symptoms. This allows fatty liver to progress to NASH.
Individuals at greatest risk of developing NASH are those who are obese, have high blood sugar, and high cholesterol.
NASH is the 2nd leading cause of liver transplants in the U.S.
“I wholeheartedly hope other people will step up and do it, so they have enough people to fully carry this through.”
“I think that people should try to help other islanders by getting this study going, and I think you should do it.”
“People have to step up and be part of the solution.
It’s nothing to be afraid of.”
“We need people to participate in studies to be able to get these things out there and get them approved.”
Why wait to help impact the future of NASH care? Participants may receive: